BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23134557)

  • 1. ACTH-secreting Crooke cell carcinoma of the pituitary.
    Kovács GL; Góth M; Rotondo F; Scheithauer BW; Carlsen E; Saadia A; Hubina E; Kovács L; Szabolcs I; Nagy P; Czirják S; Hanzély Z; Kovács K; Horváth É; Korbonits M
    Eur J Clin Invest; 2013 Jan; 43(1):20-6. PubMed ID: 23134557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triple jeopardy in the pituitary.
    Goh KP; Lee HY; Rajasoorya RC
    Pituitary; 2008; 11(3):331-6. PubMed ID: 18058238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenocorticotropic hormone-producing pituitary carcinoma with intracranial metastases.
    Shastri BR; Nanda A; Fowler M; Levine SN
    World Neurosurg; 2013 Feb; 79(2):404.e11-6. PubMed ID: 22079280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy does not accelerate corticotroph tumor progression in Nelson's syndrome.
    Jornayvaz FR; Assie G; Bienvenu-Perrard M; Coste J; Guignat L; Bertherat J; Silvera S; Bertagna X; Legmann P
    J Clin Endocrinol Metab; 2011 Apr; 96(4):E658-62. PubMed ID: 21289243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions.
    Thapar K; Scheithauer BW; Kovacs K; Pernicone PJ; Laws ER
    Neurosurgery; 1996 Apr; 38(4):765-70; discussion 770-1. PubMed ID: 8692397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression of a Nelson's adenoma to pituitary carcinoma; a case report and review of the literature.
    Kemink SA; Wesseling P; Pieters GF; Verhofstad AA; Hermus AR; Smals AG
    J Endocrinol Invest; 1999 Jan; 22(1):70-5. PubMed ID: 10090141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pituitary corticotroph hyperplasia preceding adenoma in a patient with Nelson's syndrome.
    Kovacs K; Horvath E; Coire C; Cusimano M; Smyth H; Scheithauer BW; Lloyd RV
    Clin Neuropathol; 2006; 25(2):74-80. PubMed ID: 16550740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cushing's disease due to double pituitary ACTH-secreting adenomas: the first case report.
    Andrioli M; Pecori Giraldi F; Losa M; Terreni M; Invitti C; Cavagnini F
    Endocr J; 2010; 57(9):833-7. PubMed ID: 20595779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical type II silent corticotrophic adenoma developing into Cushing's disease upon second recurrence.
    Psaras T; Honegger J; Buslei R; Saeger W; Klein D; Capper D; Meyermann R; Mittelbronn M
    Exp Clin Endocrinol Diabetes; 2007 Oct; 115(9):610-5. PubMed ID: 17943697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoplexy of Crooke cell tumour leading to the diagnosis of severe Cushing disease; a case report.
    de Silva NL; Somasundaram N; Constantine R; Kularatna H
    BMC Endocr Disord; 2021 May; 21(1):93. PubMed ID: 33933049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pituitary atypical adenoma or malignant corticotrophinoma?].
    Alves M; Paiva I; Belo F; Rebelo O; Bastos M; Carvalheiro M
    Acta Med Port; 2011 Dec; 24 Suppl 3():661-6. PubMed ID: 22856408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathobiology of pituitary adenomas and carcinomas.
    Scheithauer BW; Gaffey TA; Lloyd RV; Sebo TJ; Kovacs KT; Horvath E; Yapicier O; Young WF; Meyer FB; Kuroki T; Riehle DL; Laws ER
    Neurosurgery; 2006 Aug; 59(2):341-53; discussion 341-53. PubMed ID: 16883174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Silent"corticotropinoma.
    Pawlikowski M; Kunert-Radek J; Radek M
    Neuro Endocrinol Lett; 2008 Jun; 29(3):347-50. PubMed ID: 18580839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastasis to pituitary adenoma: case report and review of the literature.
    Hoellig A; Niehusmann P; Flacke S; Kristof RA
    Cent Eur Neurosurg; 2009 Aug; 70(3):149-53. PubMed ID: 19701874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinomas of the pituitary: definition and review of the literature.
    Lübke D; Saeger W
    Gen Diagn Pathol; 1995 Oct; 141(2):81-92. PubMed ID: 8548598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cushing disease 30 years ago. Now noticeable brown skin pigment].
    Barthel A; Voigt A; Gruber M; Bornstein SR; Benker G
    MMW Fortschr Med; 2009 Sep; 151(38):4. PubMed ID: 19831168
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-Term Survival After Transformation of an Adrenocorticotropic Hormone-Secreting Pituitary Macroadenoma to a Silent Corticotroph Pituitary Carcinoma.
    Rotman LE; Vaughan TB; Hackney JR; Riley KO
    World Neurosurg; 2019 Feb; 122():417-423. PubMed ID: 30447452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant pituitary corticotroph adenomas: report of two cases and a comprehensive review of the literature.
    van der Klaauw AA; Kienitz T; Strasburger CJ; Smit JW; Romijn JA
    Pituitary; 2009; 12(1):57-69. PubMed ID: 18176844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical pathology of the pituitary: the adenomas. Part II.
    Scheithauer BW
    Pathol Annu; 1984; 19 Pt 2():269-329. PubMed ID: 6150459
    [No Abstract]   [Full Text] [Related]  

  • 20. No effect of the PPAR-gamma agonist rosiglitazone on ACTH or cortisol secretion in Nelson's syndrome and Cushing's disease in vitro and in vivo.
    Kreutzer J; Jeske I; Hofmann B; Blumcke I; Fahlbusch R; Buchfelder M; Buslei R
    Clin Neuropathol; 2009; 28(6):430-9. PubMed ID: 19919817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.